INTARCIA THERAPEUTICS, INC — Form D/A

INTARCIA THERAPEUTICS, INC of HAYWARD, CA, a company, filed a Form D amendment with the SEC on 2017-08-04. The offering totals $850.0M, of which $524.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (75)

Showing 25 of 75 people.

NameRoleLocation
Emad RizkDirectorBoston, MA
Glen SatoDirectorSanta Clara, CA
Irwin ScherDirectorBoston, MA
Michelle BaronExecutive OfficerBoston, MA
Owen Hughes, Jr.Executive OfficerBoston, MA
John YeeExecutive OfficerSarasota, FL
Sunita ZalaniExecutive OfficerBoston, MA
Michael WilliamsExecutive OfficerNew York, NY
Jay SkylerDirectorMiami Beach, FL
Bryan RobertsDirectorBoulder, CO
James AhlersExecutive OfficerHayward, CA
Gino SantiniDirectorCambridge, MA
Kurt GravesDirectorHayward, CA
Kurt GravesExecutive OfficerHayward, CA
Bryan L RobertsDirectorPleasanton, CA
David FranklinExecutive OfficerGainesville, FL
Jay SmithExecutive OfficerDavis, CA
PATRICK CONWAYDirectorTACOMA, WA
Barbara G McClungExecutive OfficerBerkeley, CA
Ed MathersDirectorTIMONIUM, MD
Paul FeldmanExecutive OfficerWilmington, DE
Jim RosenthalDirectorNew York, NY
Nancy ThornberryDirectorBoston, MA
Anders VintherExecutive OfficerBoston, MA
Bob KerreyDirectorBoston, MA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2020-01-14D/A$280.0M$198.5M
2019-03-12D$150.0M$73.1M
2017-04-03D/A$650.0M$475.7M
2017-01-13D$4K$4K
2017-01-06D/A$650.0M$390.7M
2016-09-15D$600.0M$184.4M
2014-04-07D$200.0M$200.0M
2012-11-29D$160.0M$155.9M
2012-11-29D$7.9M$7.9M
2012-11-29D$699K$699K
2012-08-30D/A$47.5M$45.8M
2012-08-22D$7.3M$7.3M
2011-08-25D/A$44.0M$40.3M
2011-06-10D/A$29.0M$27.0M
2010-09-07D$15.0M$5.0M

More